Figure 6From: Impact of innate immunity in a subset of children with autism spectrum disorders: a case control studyLower sTNFRII production with a TLR7/8 agonist in the ASD test group following LPS pre-treatment. sTNFRII production with a TLR7/8 agonist was lower in the ASD test group than in normal case controls.Back to article page